Institute for International Research

Know how to achieve

Main menu

My IBC

Login form

Sign Up

Formulation Strategies for Protein Therapeutics

Event Information

Held concurrently with IBC's BioProcess International Conference and Exposition
Formulating the Next Generation of Protein Therapeutics: Pre-Filled Syringes, High Concentration Proteins, Quality by Design and Novel Protein Structures
September 23 - 25, 2008 · Disneyland® Hotel · Anaheim, CA

Document Title

Distinguished Faculty

Distinguished Faculty

  • Siddharth J. Advant, Ph.D., Tunnell Consulting
  • Advait Badkar, Ph.D., Pfizer Inc
  • Anthony B. Barry, Ph.D., Wyeth BioPharma
  • Steven Bishop, Ph.D., MedImmune, Inc.
  • Jason Bock, Ph.D., Teva Biopharmaceuticals, USA
  • Robert Yi-Te Chou, Ph.D., Amgen
  • James Colandene, Ph.D., Human Genome Sciences, Inc.
  • Tapan Das, Ph.D., Pfizer Inc
  • Jesper Davidsen, Genmab A/S, The Netherlands
  • Adam Dinerman, Ph.D., Centocor, Inc.
  • Osigwe Esue, Ph.D., Genentech, Inc.
  • David J. Geer, Ph.D., Merck and Co., Inc.
  • Merrill Goldenberg, Ph.D., Amgen
  • Nicholas Guziewicz, Genzyme Corporation
  • David D. Hile, Ph.D., Stryker Biotech
  • Carl "Charlie" Hitscherich Jr., Ph.D., Biogen Idec, Inc.
  • Robin Hwang, Ph.D., Amgen
  • Sonoko Kanai, Ph.D., F. Hoffmann-La Roche Ltd., Switzerland
  • Angela Kantor, Wyeth Biopharma
  • Yeu Chun Kim, Ph.D., Georgia Institute of Technology
  • Carol F. Kirchhoff, Ph.D., Pfizer Inc
  • Tom Leach, Ph.D., MedImmune, Inc.
  • Li Li, Ph.D., Wyeth BioPharma
  • Michiel Lodder, Ph.D., OctoPlus Inc.
  • Haripada Maity, Ph.D., ImClone Systems Incorporated
  • Susan W. H. Martin, Ph.D., Pfizer Inc
  • Thomas J. Nikolai, Abbott Laboratories
  • Joseph Phillips, Ph.D., Amgen
  • Dov H. Pluznik, Ph.D., United States Food and Drug Administration
  • Christian Rischel, Ph.D., Novo Nordisk A/S, Denmark
  • Jennifer L. Riter, West Pharmaceutical Services
  • Niles Ron, Ph.D., MBA, Seattle Genetics, Inc.
  • Timothy J. Shea, Jr., Sterne, Kessler, Goldstein & Fox P.L.L.C.
  • Thomas M. Spitznagel, Ph.D., Human Genome Sciences, Inc.
  • Arvind Srivastava, Ph.D., ImClone Systems Incorporated
  • Ping Yeh, Ph.D., Biogen Idec, Inc.
  • Gaozhong Zhu, Ph.D., Shire Human Genetic Therapies, Inc.

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group

Powered by Interactive Agency Janmedia Interactive, Inc.